{ "items": [ "\n\n
\n \n\n \n \n \n \n OPDC News\n \n \n\n \n\n\n
\n \n\n \n26 February 2020
\n \n \n \n\n \n \n\n \n\n \n \n \n \n EDI News\n \n \n \n \n OPDC News\n \n \n \n \n Wade-Martins Group News\n \n \n\n \n\n\n
\n \n\n \n13 December 2019
\n \n \n \n\n \n \n\n \n\n \n \n \n \n OPDC News\n \n \n\n \n\n\n
\n \n\n \n12 December 2019
\n \n \n \n\n \n \n\n \n\n \n \n \n \n Cragg Group News\n \n \n \n \n OPDC News\n \n \n \n \n Publication\n \n \n \n \n Research\n \n \n \n \n Wade-Martins Group News\n \n \n\n \n\n\n
\n \n\n \n4 November 2019
\n \n \n \nOur Researchers at the Oxford Parkinson\u2019s Disease Centre have shown that cell recycling in Parkinson\u2019s may play a more complex role than previously thought.
\n \n\n \n \n\n \n\n \n \n \n \n OPDC News\n \n \n\n \n\n\n
\n \n\n \n1 November 2019
\n \n \n \nContinuing their series celebrating \u2018amazing people at Oxford who you should know about\u2019, Central University's Science Blog talks to Dayne Beccano-Kelly, an electrophysiologist and Career Development Fellow in our department and part of the Oxford Parkinson\u2019s Disease Centre.
\n \n\n \n \n\n \n\n \n \n \n \n EDI News\n \n \n \n \n OPDC News\n \n \n \n \n Wade-Martins Group News\n \n \n\n \n\n\n
\n \n\n \n1 November 2019
\n \n \n \nContinuing their series celebrating \u2018amazing people at Oxford who you should know about\u2019, Central University's Science Blog talks to Dayne Beccano-Kelly, an electrophysiologist and Career Development Fellow in our department and part of the Oxford Parkinson\u2019s Disease Centre.
\n \n\n \n \n\n \n\n \n \n \n \n OPDC News\n \n \n\n \n\n\n
\n \n\n \n31 October 2019
\n \n \n \nOur Researchers at the Oxford Parkinson\u2019s Disease Centre have shown that cell recycling in Parkinson\u2019s may play a more complex role than previously thought.
\n \n\n \n \n\n \n\n \n \n \n \n OPDC News\n \n \n\n \n\n\n
\n \n\n \n29 October 2019
\n \n \n \nStewart Humble came to the Wade-Martins Lab at DPAG from Louisiana State University Health Sciences Center in New Orleans during Michaelmas Term in October 2016 as part of the National Institutes of Health Oxford-Cambridge Scholars Programme (NIH-OxCam), an accelerated, individualised doctoral training programme, to help him make the transition to a Physician-Scientist career path. This opened up the world of basic science, translational research, and international collaboration. Over the summer of 2019, Stewart organised a lab symposium to encourage and inspire students from his home university to consider the opportunities available to them. This is the story of his journey to Oxford and what he has discovered here.
\n \n\n \n \n\n \n\n \n \n \n \n EDI News\n \n \n \n \n Long Read\n \n \n \n \n OPDC News\n \n \n \n \n Outreach\n \n \n \n \n Students\n \n \n \n \n Wade-Martins Group News\n \n \n\n \n\n\n
\n \n\n \n29 October 2019
\n \n \n \nStewart Humble came to the Wade-Martins Lab at DPAG from Louisiana State University Health Sciences Center in New Orleans during Michaelmas Term in October 2016 as part of the National Institutes of Health Oxford-Cambridge Scholars Programme (NIH-OxCam), an accelerated, individualised doctoral training programme, to help him make the transition to a Physician-Scientist career path. This opened up the world of basic science, translational research, and international collaboration. Over the summer of 2019, Stewart organised a lab symposium to encourage and inspire students from his home university to consider the opportunities available to them. This is the story of his journey to Oxford and what he has discovered here.
\n \n\n \n \n\n \n\n \n \n \n \n OPDC News\n \n \n\n \n\n\n
\n \n\n \n28 October 2019
\n \n \n \nOctober is Black History Month, which is celebrated nationwide every year to recognise the contributions that people from BAME backgrounds have made to this country. Here at DPAG, we get to know one of our Researchers - Pavandeep Rai, a Postdoctoral Research Scientist working in the Wade-Martins Group. Pavandeep is working at the forefront of an industry/academia collaborative project aimed at developing potential new drugs to treat Parkinson\u2019s.
\n \n\n \n \n\n \n\n \n \n \n \n EDI News\n \n \n \n \n Long Read\n \n \n \n \n OPDC News\n \n \n \n \n Postdoctoral\n \n \n \n \n Wade-Martins Group News\n \n \n\n \n\n\n
\n \n\n \n28 October 2019
\n \n \n \nOctober is Black History Month, which is celebrated nationwide every year to recognise the contributions that people from BAME backgrounds have made to this country. Here at DPAG, we get to know one of our Researchers - Pavandeep Rai, a Postdoctoral Research Scientist working in the Wade-Martins Group. Pavandeep is working at the forefront of an industry/academia collaborative project aimed at developing potential new drugs to treat Parkinson\u2019s.
\n \n\n \n \n\n \n\n \n \n \n \n EDI News\n \n \n \n \n OPDC News\n \n \n \n \n Outreach\n \n \n \n \n Research\n \n \n \n \n Wade-Martins Group News\n \n \n\n \n\n\n
\n \n\n \n2 August 2019
\n \n \n \nDr Nora Bengoa-Verginory and Bryan Ng from the Wade-Martins Group were invited to deliver talks showcasing their research at the annual event from the Alzheimer\u2019s Research UK Oxford network.
\n \n\n \n \n\n \n\n \n \n \n \n OPDC News\n \n \n\n \n\n\n
\n \n\n \n1 August 2019
\n \n \n \nOur researchers have found that a simple test carried out on a smartphone can help to predict future change in people in the early stages of Parkinson\u2019s.
\n \n\n \n \n\n \n\n \n \n \n \n Cragg Group News\n \n \n \n \n EDI Events\n \n \n \n \n Goodwin Group News\n \n \n \n \n Head of Department's News\n \n \n \n \n Integrative Neuroscience\n \n \n \n \n OPDC News\n \n \n \n \n Postdoctoral\n \n \n \n \n Research\n \n \n \n \n Students\n \n \n \n \n Vyazovskiy Group News\n \n \n \n \n Wade-Martins Group News\n \n \n\n \n\n\n
\n \n\n \n6 June 2019
\n \n \n \nThe talks given by Postdoctoral Research Scientists and Graduate Students highlighted the full range of research in DPAG, spanning molecular and cellular neuroscience all the way to systems neuroscience.
\n \n\n \n \n\n \n\n \n \n \n \n OPDC News\n \n \n\n \n\n\n
\n \n\n \n4 June 2019
\n \n \n \nOur new paper is one of the first to report genome-wide transcriptomic RNA-Seq profiling of stem cell-derived astrocytes from people with Parkinson's & healthy controls.
\n \n\n \n \n\n \n\n \n \n \n \n OPDC News\n \n \n\n \n\n\n
\n \n\n \n21 May 2019
\n \n \n \n\n \n \n\n \n\n \n \n \n \n EDI News\n \n \n \n \n OPDC News\n \n \n \n \n Outreach\n \n \n \n \n Postdoctoral\n \n \n \n \n Wade-Martins Group News\n \n \n\n \n\n\n
\n \n\n \n21 May 2019
\n \n \n \n\n \n \n\n \n\n \n \n \n \n OPDC News\n \n \n\n \n\n\n
\n \n\n \n2 May 2019
\n \n \n \nThe Wade-Martins Group has identified how the dysfunction of a key protein, LRRK2, causes the neurons affected in Parkinson's to lose their ability to effectively clear out cell components that have been damaged. This discovery has enabled the team to find a new way to target and correct this issue, paving the way for a potential new clinical treatment.
\n \n\n \n \n\n \n\n \n \n \n \n OPDC News\n \n \n \n \n Publication\n \n \n \n \n Research\n \n \n \n \n Wade-Martins Group News\n \n \n\n \n\n\n
\n \n\n \n2 May 2019
\n \n \n \nThe Wade-Martins Group has identified how the dysfunction of a key protein, LRRK2, causes the neurons affected in Parkinson's to lose their ability to effectively clear out cell components that have been damaged. This discovery has enabled the team to find a new way to target and correct this issue, paving the way for a potential new clinical treatment.
\n \n\n \n \n\n \n\n \n \n \n \n OPDC News\n \n \n\n \n\n\n
\n \n\n \n11 April 2019
\n \n \n \nNew study finds mutations in the gene LRRK2 affect normal cell function.
\n \n\n \n \n